000 04512nam a22003737a 4500
001 20241107112428.0
003 OCoLC
005 20241107112918.0
008 241107b |||||||| |||| 00| 0 eng d
010 _a 2016951645
020 _a978-3-319-33677-0
020 _a 978-3-319-33679-4 (eBook)
022 _a 1613-5318
022 _a 2191-0812 (electronic)
040 _cddc
041 _aEnglish
100 _qArchie Bleyer
222 _a Cancer in Adolescents and Young Adults.
_bacute lymphoblastic leukemia adjuvant adolescents adolescents and young adult survivors adults with cancer Age at Diagnosis age group asparaginase associated AYA AYA cancer AYA patients biology Bleyer bone brain tumors breast cancer cancer patients carcinoma cer chemotherapy childhood cancer survivors Children's Oncology Group Clin Oncol clinical trials cohort disease dose evaluation females Fig follow-up function gene genetic germ cell tumors healthcare hepatocellular carcinoma histologic Hodgkin lymphoma impact improve incidence increased invasive late effects liver long-term lymph node males malignant melanoma metastases mutations National Cancer non-Hodgkin lymphoma older adults oncologists Oncology Group osteosarcoma outcomes ovarian Pediatr Blood Cancer Pediatric Oncology population prognostic programs psychosocial radiation radiotherapy regimen relapse reported resection SEER sexual soft tissue sarcomas stage subtypes surgery surgical survival rate survivors of childhood syndrome synovial sarcoma T-cell testicular therapy thyroid cancer tion transplantation treated treatment United women young adult cancer younger
240 _a Cancer in Adolescents and Young Adults.
245 _a Cancer in Adolescents and Young Adults.
250 _a2nd. Edition.
260 _aBend OR USA |
_b Springer International Publishing AG |
_c 2017.
300 _a830 Pages
300 _aIncludes References.
490 _aPediatric Oncology.
520 _aThis is the second edition of the only book to be devoted exclusively to the total cancer picture in adolescents and young adults (AYA), now expanded from the age range 15-29 to that of 15–39 years. For each of the diverse spectrum of cancers encountered in the AYA group, the epidemiology, natural progression, diagnostic approaches, and treatment options are described, with special emphasis on strategies for early detection and prevention. Comparison is made with management of both younger and older patients, and model programs are presented that address common diagnostic, staging, treatment, and psychosocial shortcomings in the AYA group. Detailed attention is also paid to principles and practices of care, with consideration of psychosocial and quality of life issues, social support systems, rehabilitation, late effects, insurance, and economic aspects of health care, among other topics. The authors make compelling arguments for integrated strategies that allow young adults to benefit from the combined expertise of pediatric and adult oncologists in systems that identify both the complex disease and the social issues specific to this population. The proposed models of care include relationships with other specialties that do not specifically target this age group, i.e., infectious disease, endocrinology, pulmonary medicine, nephrology, gastroenterology, thoracic and abdominal surgery, urology, otolaryngology, and neurosurgery. New patterns of communication are advocated and endorsed as essential for productive interaction involving these specialties. References are extensive and are oriented toward users in pediatric hematology-oncology medical oncology, radiation oncology, surgical oncology, gynecologic oncology, oncology nursing, psycho-oncology, social work, epidemiology, public health and health services research. The contributing authors are from the United States, the United Kingdom, Canada, Italy, France, Israel, Switzerland and Australia, Germany, Japan and the Netherlands.
600 _xMedical / Clinical Medicine, Medical / Oncology / General, Medical / Pediatrics, Medical / Public Health, Oncology, Pediatrics, Public health, Medical / Oncology / Pediatric, Adulthood, Cancer in adolescence, Human beings, Medicine, Medicine and Public Health, Young adults.
700 _qRonald Barr
700 _q Lynn Ries
700 _q Jeremy Whelan
700 _q Andrea Ferrari
856 _uDOI 10.1007/978-3-319-33679-4
942 _2ddc
_cEB
_n0
999 _c29711
_d29711